21017 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Transferrins, e.g. lactoferrins, ovotransferrins
Acellular bioabsorbable tissue regeneration matrices
#302COMPOSITIONS AND METHODS FOR REDUCING EDEMA
#303Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof
#304Antimicrobial composition and uses thereof
#305BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE
#306BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH
#307P97 fragments with transfer activity
#308Treatment for Concussion using Gallium Compounds
#309ECZEMA TREATMENT
#310Removing endotoxin from proteins
#311COLD TREATMENT
#312PHARMACEUTICAL COMPOSITIONS
#313Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
#314Topical wound management formulation
#315Compositions for mucosal delivery of agents
#316Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
#317METHODS, KITS AND COMPOSITIONS FOR AMELIORATING ADVERSE EFFECTS ASSOCIATED WITH TRANSFUSION OF AGED RED BLOOD CELLS
#318LACTOFERRIN IN THE TREATMENT OF MALIGNANT NEOPLASMS AND OTHER HYPERPROLIFERATIVE DISEASES
#319Lactoferrin and gut neuronal health in adults and/or elderly
#320Natural polypeptides for oral health care
#321MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#322USE OF TNF-ALPHA INHIBITORS FOR TREATING A NERVE DISORDER MEDIATED BY NUCLEUS PULPOSUS
#323Transfection reagents
#324Method of treatment using solubilized protein composition obtained from eggshell membrane
#325Glycopegylation methods and proteins/peptides produced by the methods
#326NUTRITIONAL COMPOSITIONS COMPRISING LACTOFERRIN AND PROBIOTICS AND KITS OF PARTS THEREOF
#327Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
#328Lactoferrin and brain health and development in infants
#329Lactoferrin and neuronal health and development in the infant gut
#330Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#331USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO DISEASES AND CONDITIONS
#332USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN STIMULATING IMMUNE CELLS
#333Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
#334USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS
#335METHOD FOR INHIBITING A BACTERIAL INVASIVE MECHANISM USING A NUTRITIONAL COMPOSITION
#336Influenza prevention and treatment composition
#337COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS
#338Methods of inhibiting and treating bacterial biofilms by metal chelators
#339LACTOFERRIN AND BRAIN HEALTH AND PROTECTION IN ADULTS
#340Lactoferrin-based biomaterials for tissue regeneration and drug delivery
#341ANTI-MENTAL FATIGUE DRUG
#342Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
#343Non-glycosylated transferrin expressed in monocots
#344ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME
#345Composition for preventing and treating fatty liver
#346METHOD OF WHITENING SKIN
#347Method for removing endotoxin from proteins
#348Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
#349HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION
#350TREATING OR PREVENTING ROTAVIRUS INFECTION
#351Surgical adjuvant composition and associated methods of use
#352Lactoferrin and angiogenin compositions and uses thereof
#353COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION
#354NUTRITIONAL SUPPORT OF THE IMMUNE SYSTEM DURING ANTI-CANCER TREATMENT
#355NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT
#3564 aminopyridine and a pharmaceutical composition for treatment of neuronal disorders
#357Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
#358Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
#359Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
#360Taxane- and taxoid-protein compositions
#361Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
#362METHODS OF IMMUNE OR HEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER, CANCER SYMPTOMS, OR THE SYMPTOMS OF CANCER TREATMENTS
#363METHODS AND COMPOSITIONS
#364Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#365Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#366Methods comprising serratia peptidase for inhibition of osteomyelitis
#367Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#368Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis
#369Heat-stable, aqueous lactoferrin composition and its preparation and use
#370COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#371Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#372INTESTINAL ENVIRONMENT-IMPROVING AGENT
#373Compositions for mucosal delivery of agents
#374Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
#375Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
#376Defined culture conditions of human embryonic stem cells
#377USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES
#378THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING GRAM-NEGATIVE BACTERIAL INFECTIONS
#379Process for solubilizing protein from a proteinaceous material and compositions thereof
#380Solubilized protein composition obtained from avian eggshell membrane
#381NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#382Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid
#383BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF
#384Methods to increase or decrease bone density
#385SOULUBLE B-N-ACETYLGLUCOSEAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF
#386Treatment Method
#387COMPOSITIONS CONTAINING LACTOFERRIN, AND METHODS OF USING SAME TO PROMOTE GROWTH OF SKIN CELLS
#388NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS
#389PROPHYLATIC AGENT FOR AUTOIMMUNE DISEASE
#390Method of imparting heat resistance to lactoferrin
#391Dry treatment mixture and methods of production and use
#392NOVEL USE OF CYTOKINE INHIBITORS
#393Biofilm prevention using lactoferrin
#394MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
#395METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY
#396PANCREATIC ISLET CELLS COMPOSITION AND METHODS
#397Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
#398INGESTIBLE FILM COMPOSITION
#399Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin
#400SKIN WHITENING AGENT
#401LACTOFERRIN AS A RADIOPROTECTIVE AGENT
#402ANTI-INFLAMMATORY COMPOSITION COMPRISING GLYCINE AND LACTOFERRIN AND THE USE THEREOF
#403ORAL LACTOFERRIN IN THE TREATMENT OF SEPSIS
#404USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#405Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#406Compositions and methods for modulating blood-brain barrier transport
#407Methods for reducing the incidence of mastitis
#408Transfection reagents
#409Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
#410Compositions and methods for enzymatic treatment of lung disorders
#411Natural polypeptides for oral health care
#412INTRATUMORALLY ADMINISTERED LACTOFERRIN IN THE TREATMENT OF MALIGNANTNEOPLASMS AND OTHER HYPERPROLIFERATIVE DISEASES
#413METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES
#414Diagnosis and treatment of preeclampsia
#415METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER
#416Methods and compositions for sealing and adhering biological tissues and medical uses thereof
#417Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
#418Glycopegylation methods and proteins/peptides produced by the methods
#419Methods of Use of Eggshell Polypeptides
#420Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
#421TARGETED BIOCIDES
#422Solubilized protein composition obtained from eggshell membrane
#423COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS
#424Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent
#425Use of composition for manufacture of medicant and method for inhibiting formation of body fat
#426Composition for preventing and treating fatty liver
#427ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION
#428Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
#429Salivary substitute
#430Antimicrobial composition and uses thereof
#431SMALL MOLECULES FOR THE REDUCTION OF HIGH BLOOD GLUCOSE LEVEL
#432Wound Care Treatment Product
#433USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
#434Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
#435METHODS FOR INCREASING HYALURONIC ACID LEVELS AND IMPROVING MOISTURE RETENTION IN TISSUE
#436METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER
#437Series spring blade tensioner
#438Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
#439Methods of treating destructive inflammation of the mucous membranes with lactoferrin
#440Methods for reduction of adhesion formation using cytokine inhibitors
#441Metallo-protein and tocotrienol (MP-T3) compositions and uses thereof
#442Transfection reagents
#443Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C
#444Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin
#445Peptide compounds for treating obesity and insulin resistance
#446Process for solubilizing protein from a proteinaceous material and compositions thereof
#447AGENT FOR AMELIORATING HEAVY METAL-INDUCED DISORDERS, AND MEDICINAL COMPOSITION, FOOD AND COSMETIC CONTAINING THE SAME
#448EXTERNAL PREPARATION FOR IMPROVING COITAL FUNCTION
#449METHODS FOR TREATING BACILLUS INFECTION
#450Method for removing endotoxin from proteins
#451Anti-hypertensive functional food products
#452USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#453Composition Comprising Silver Nanoparticles and the Use Thereof
#454Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof
#455Method of screening for substances which proliferate natural killer cells
#456Method for proliferating natural killer cells
#457Biocides
#458Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
#459Methods to increase or decrease bone density
#460Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
#461METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS
#462Milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases
#463Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
#464INFLUENZA PREVENTION AND TREATMENT COMPOSITION
#465Antimicrobial Compositions
#466Dermatologic use of milk proteins
#467Lycopene Formulations For the Treatment of Atherosclerotic Conditions
#468METHODS OF USING ARTEMISININ-LIKE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER
#469Lactoferrin in the reduction of pain
#470Milk protein isolate and process for its preparation
#471Alkaline phosphatase compositions to reduce skin cancer
#472COMPOSITIONS AND METHODS FOR ENHANCING VASODILATION
#473METHODS FOR IMPROVED LIPID METABOLISM AND BASAL METABOLIC RATE WITH LACTOFERRIN
#474Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#475Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
#476Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
#477USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#478Antioxidant compositions for the eye
#479Transfection reagents
#480Transfection reagents
#481Acellular bioabsorbable tissue regeneration matrices
#482Methods for inhibiting the growth of bacteria
#483Process for reducing the concentration of blood glucose in a diabetic patient
#484Composition for reducing blood lipids
#485Dairy components effective for fat loss
#486Compositions for modulating blood-brain barrier transport
#487Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
#488Personal Communication Center Performance Display and Status Alert System
#489Insult induced immune dissonance
#490Interferon antagonists useful for the treatment of interferon related diseases
#491TRANSFERRIN AND TRANSFERRIN-BASED COMPOSITIONS FOR DIABETES TREATMENT
#492COMPOSITIONS AND METHODS TO ENHANCE VIABILITY AND FUNCTION OF ISLET CELLS
#493DIETARY SUPPLEMENT
#494Compositions for disrupting and inhibiting reconstitution of wound biofilm
#495Novel methods and medicament for treating infectious diseases involving microbial biofilms
#496Drug and method for proliferating natural killer cells
#497Method for inhibiting bacterial colonisation
#498Targeted biocides
#499Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
#500Bioactive complexes compositions and methods of use thereof
#501Therapeutic composition for the treatment of dry eye syndrome
#502Encapsulated arsenic drugs
#503COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH
#504Compound and method for regulating plasminogen activation and cell migration
#505Glycopegylation methods and proteins/peptides produced by the methods
#506Method for promoting hair growth
#507Protein compositions for promoting wound healing and skin regeneration
#508Composition for preventing and treating cardiovascular disorders
#509Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin
#510Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
#511Lysozyme-based food stuff
#512Storage and delivery vessel for two-part medicament
#513Method and ophthalmic formulation for eye protection or treatment
#514Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
#515Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
#516Bioactive factors in wound healing topical compositions and methods
#517Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
#518Method of improving nutrient utilisation by a mammal and a composition for use therein
#519External preparation for improving coital function
#520Lactoferrin in the treatment of diabetes mellitus
#521Personal communication center performance display and status alert system
#522Biocides
#523Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
#5244-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders
#525Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
#526Treatment for dry eye syndrome
#527Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
#528Milk protein isolate and method for preparing same
#529Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#530Composition for reducing blood lipids
#531Cutanceous metabolic bio-activator
#532Compositions for mucosal delivery of agents
#533Compositions comprising lactoferrin
#534Transfection reagents
#535Dietary supplement
#536Synergistic antimicrobial compositions and methods for reducing biofilm formation
#537Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
#538Novel of cytokine inhibitors
#539Transfection reagents
#540New transfection reagents
#541Transfection reagents
#542Lactoferrin-treated filament materials
#543Lactoferrin for age related disorders in humans
#544Methods of inhibiting and treating bacterial biofilms by metal chelators
#545Transfection reagents
#546Analgesics
#547Treatment of cancers by inhalation of stable platinum-containing formulations
#548Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
#549Methods and compositions for use in pet breeding
#550Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin
#551Compositions for improving lipid metabolism
#552Lactoferrin in the treatment of diabetes mellitus
#553Anti-microbial and anti-inflammatory compositions and methods for treating enteric diseases in animals